|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
WO2004063344A2
(en)
|
2003-01-10 |
2004-07-29 |
Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health |
CATALYTIC DOMAINS OF β/1,4)-GALACTOSYLTRANSFERASE I HAVING ALTERED DONOR AND ACCEPTOR SPECIFICITIES, DOMAINS THAT PROMOTE IN VITRO PROTEIN FOLDING, AND METHODS FOR THEIR USE
|
|
US8759490B2
(en)
|
2005-03-24 |
2014-06-24 |
Millennium Pharamaceuticals, Inc. |
Antibodies that bind OV064 and methods of use therefor
|
|
EP3058955B1
(en)
|
2005-03-24 |
2019-05-29 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind ov064 and methods of use therefor
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
AU2006321553B2
(en)
|
2005-12-08 |
2012-03-08 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies to O8E
|
|
US9121853B2
(en)
|
2006-03-20 |
2015-09-01 |
Mayo Foundation For Medical Education And Research |
B7-H4 expression on tumor vasculature
|
|
EP2109455A2
(en)
|
2006-12-27 |
2009-10-21 |
The Johns Hopkins University |
Compositions and methods for stimulating an immune response
|
|
EA201000910A1
(ru)
|
2007-11-30 |
2011-04-29 |
Бристоль-Мейерз Сквибб Компани |
Конъюгат "моноклональное антитело против в7н4/лекарственное средство" и способы его применения
|
|
WO2009102820A2
(en)
|
2008-02-11 |
2009-08-20 |
Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services |
Modified sugar substrates and methods of use
|
|
US8852599B2
(en)
|
2011-05-26 |
2014-10-07 |
Bristol-Myers Squibb Company |
Immunoconjugates, compositions for making them, and methods of making and use
|
|
WO2012171020A1
(en)
|
2011-06-10 |
2012-12-13 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
JP6120848B2
(ja)
|
2011-08-15 |
2017-04-26 |
メディミューン，エルエルシー |
抗ｂ７−ｈ４抗体およびその使用
|
|
GB201115841D0
(en)
|
2011-09-13 |
2011-10-26 |
Genovis Ab |
Protein and method
|
|
WO2013067492A1
(en)
|
2011-11-03 |
2013-05-10 |
The Trustees Of The University Of Pennsylvania |
Isolated b7-h4 specific compositions and methods of use thereof
|
|
AU2013361275B2
(en)
|
2012-12-19 |
2016-11-24 |
Amplimmune, Inc. |
Anti-human B7-H4 antibodies and their uses
|
|
AU2014244424A1
(en)
|
2013-03-14 |
2015-08-27 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
|
US9562099B2
(en)
|
2013-03-14 |
2017-02-07 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
|
EA032231B1
(ru)
|
2013-10-11 |
2019-04-30 |
Мерсана Терапьютикс, Инк. |
Конъюгаты белок-полимер-лекарственное средство
|
|
JP6943760B2
(ja)
|
2014-09-12 |
2021-10-06 |
ジェネンテック， インコーポレイテッド |
抗ｂ７−ｈ４抗体及び免疫複合体
|
|
WO2016070001A1
(en)
|
2014-10-31 |
2016-05-06 |
Jounce Therapeutics, Inc. |
Methods of treating conditions with antibodies that bind b7-h4
|
|
CN107810273B
(zh)
*
|
2015-04-23 |
2022-09-27 |
西纳福克斯股份有限公司 |
用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法
|
|
US10858641B2
(en)
|
2016-02-08 |
2020-12-08 |
Synaffix B.V. |
Enzymes for trimming of glycoproteins
|
|
WO2018021301A1
(ja)
|
2016-07-26 |
2018-02-01 |
静岡県 |
抗ｂ７－ｈ４抗体
|
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
WO2018195302A1
(en)
|
2017-04-19 |
2018-10-25 |
Bluefin Biomedicine, Inc. |
Anti-vtcn1 antibodies and antibody drug conjugates
|
|
US10814011B1
(en)
|
2017-06-16 |
2020-10-27 |
Nantbio, Inc. |
Anti-B7-H4 antibodies and methods
|
|
EP3672990A1
(en)
|
2017-08-25 |
2020-07-01 |
Five Prime Therapeutics, Inc. |
B7-h4 antibodies and methods of use thereof
|
|
CN112566934B
(zh)
|
2018-01-23 |
2024-09-17 |
奈斯科尔公司 |
B7-h4抗体及其使用方法
|
|
EP3753951A4
(en)
|
2018-02-11 |
2022-03-16 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
ANTI-B7-H4 ANTIBODIES, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF
|
|
JP2021514379A
(ja)
|
2018-02-21 |
2021-06-10 |
ファイブ プライム セラピューティクス， インコーポレイテッド |
Ｂ７−ｈ４抗体製剤
|
|
EP3755719A1
(en)
|
2018-02-21 |
2020-12-30 |
Five Prime Therapeutics, Inc. |
B7-h4 antibody dosing regimens
|
|
CN108948204B
(zh)
|
2018-06-15 |
2023-01-13 |
苏州旭光科星抗体生物科技有限公司 |
抗人b7-h4单克隆抗体、鉴定方法、应用和试剂盒
|
|
WO2020081497A1
(en)
|
2018-10-15 |
2020-04-23 |
Five Prime Therapeutics, Inc. |
Combination therapy for cancer
|
|
AU2019369340A1
(en)
|
2018-10-29 |
2021-05-20 |
Mersana Therapeutics, Inc. |
Cysteine engineered antibody-drug conjugates with peptide-containing linkers
|
|
MX2021014960A
(es)
|
2019-06-06 |
2022-03-04 |
Shanghai Hansoh Biomedical Co Ltd |
Conjugado de farmaco-anticuerpos anti-b7-h4 y uso medicinal del mismo.
|
|
IL294321B1
(en)
|
2020-01-09 |
2026-04-01 |
Mersana Therapeutics Inc |
Antibody-drug conjugates are attached at a specific site with linkers that include peptides.
|
|
US20230112085A1
(en)
|
2020-01-30 |
2023-04-13 |
Apeximmune Therapeutics Inc. |
Anti-b7-h4 constructs and uses thereof
|
|
CA3168613A1
(en)
|
2020-03-18 |
2021-09-23 |
Genmab A/S |
Antibodies binding to b7h4
|
|
WO2021202984A1
(en)
|
2020-04-02 |
2021-10-07 |
Mersana Therapeutics, Inc. |
Antibody drug conjugates comprising sting agonists
|
|
TWI821699B
(zh)
|
2020-06-30 |
2023-11-11 |
大陸商諾納生物（蘇州）有限公司 |
抗b7h4抗體及其雙抗和應用
|
|
JP2024501894A
(ja)
|
2021-01-04 |
2024-01-16 |
メルサナ セラピューティクス インコーポレイテッド |
Ｂ７ｈ４ターゲティング抗体－薬物コンジュゲートおよびその使用方法
|